Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
The journey to submitting an Investigational New Drug (IND) or Investigational Medicinal Product Dossier (IMPD) is a challenging endeavor, requiring drug developers to balance speed, risk, and future needs. To achieve a timely submission without compromising product quality or commercialization goals, a strategic and well-coordinated approach is essential.
Our infographic offers valuable insights and expert recommendations to expedite the IND/IMPD submission process. It outlines five key strategies to accelerate and optimize early drug development, ensuring that you stay ahead in the competitive pharmaceutical landscape.
In addition to these strategies, the infographic explores the pivotal role of partnering with a contract development and manufacturing organization (CDMO). By providing support in accelerating timelines, optimizing processes, and ensuring compliance with regulatory standards, CDMOs can enhance the overall success of your early development program.
Download the infographic to learn more.